Rhythm Pharmaceuticals Inc (RYTM)
38.15
-1.56
(-3.93%)
USD |
NASDAQ |
Apr 25, 16:00
38.16
+0.01
(+0.03%)
After-Hours: 20:00
Rhythm Pharmaceuticals Price to Book Value: 13.52 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 14.07 |
| April 23, 2024 | 14.17 |
| April 22, 2024 | 13.82 |
| April 19, 2024 | 13.47 |
| April 18, 2024 | 13.50 |
| April 17, 2024 | 13.62 |
| April 16, 2024 | 13.65 |
| April 15, 2024 | 14.20 |
| April 12, 2024 | 14.29 |
| April 11, 2024 | 15.08 |
| April 10, 2024 | 14.56 |
| April 09, 2024 | 15.45 |
| April 08, 2024 | 14.81 |
| April 05, 2024 | 14.36 |
| April 04, 2024 | 14.21 |
| April 03, 2024 | 14.49 |
| April 02, 2024 | 14.19 |
| April 01, 2024 | 15.12 |
| March 28, 2024 | 15.35 |
| March 27, 2024 | 14.80 |
| March 26, 2024 | 14.00 |
| March 25, 2024 | 14.05 |
| March 22, 2024 | 14.37 |
| March 21, 2024 | 14.40 |
| March 20, 2024 | 14.06 |
| Date | Value |
|---|---|
| March 19, 2024 | 13.86 |
| March 18, 2024 | 14.38 |
| March 15, 2024 | 14.17 |
| March 14, 2024 | 14.18 |
| March 13, 2024 | 14.51 |
| March 12, 2024 | 14.23 |
| March 11, 2024 | 14.35 |
| March 08, 2024 | 14.86 |
| March 07, 2024 | 14.76 |
| March 06, 2024 | 14.56 |
| March 05, 2024 | 14.61 |
| March 04, 2024 | 14.92 |
| March 01, 2024 | 15.49 |
| February 29, 2024 | 15.38 |
| February 28, 2024 | 15.72 |
| February 27, 2024 | 16.31 |
| February 26, 2024 | 16.35 |
| February 23, 2024 | 16.00 |
| February 22, 2024 | 15.42 |
| February 21, 2024 | 17.09 |
| February 20, 2024 | 17.19 |
| February 16, 2024 | 17.23 |
| February 15, 2024 | 17.67 |
| February 14, 2024 | 17.52 |
| February 13, 2024 | 17.12 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6669
Minimum
May 19 2022
18.36
Maximum
Feb 12 2024
5.150
Average
4.370
Median
May 15 2023
Price to Book Value Benchmarks
| Pfizer Inc | 1.603 |
| Insmed Inc | -- |
| Altimmune Inc | 2.635 |
| Regeneron Pharmaceuticals Inc | 3.765 |
| Viking Therapeutics Inc | 8.135 |
Price to Book Value Related Metrics
| PS Ratio | 28.42 |
| Price | 38.15 |
| Earnings Yield | -8.39% |
| Market Cap | 2.294B |